Healthcare

Neurotech Advances NTI164 Research with New Pharmacokinetic Study

Highlights,Neurotech initiates a new study following FDA decision,.,Focus is on NTI164's pharmacokinetics in healthy adults,.,Study results expected b...

4DMedical Signs Key Commercial Contract with Imaging Partners of Ora...

Highlights,Partnership,: 4DMedical has secured a,commercial contract,with,Imaging Partners of Orange County (IPOC),for CT LVAS™ and Lung Density Analy...

Anteris Technologies Sets Eyes on NASDAQ with Early-Stage IPO Filing

Highlights,Anteris,Technologies files preliminary paperwork for potential NASDAQ listing,.,Focus,remains,on flagship next-gen heart valve technology a...

Pro Medicus Shares Hit Record High Amid Strong Growth Outlook

Highlights,Record Performance,: Pro Medicus shares surged to a record high of AU$226.79 on Monday, marking a 160% increase year-over-year.,Impressive...

CSL Shares See Uptick Amid Downplayed Policy Concerns

Highlights,Shares of gain traction following reassessment of US policy risks.,CSL’s vaccine business and broader pharmaceuticals face limited potentia...

PYC Therapeutics Showcases Progress in Eye Disease Treatment at Glob...

Highlights,PYC Therapeutics presents trial data for VP-001 at a major conference.,Phase 1/2 studies focus on treating Retinitis Pigmentosa Type 11.,Pr...

Tryptamine Therapeutics Completes First Dosing in Obesity Study for...

Highlights,Clinical Progress:,First subject dosed in a Phase 1b study evaluating TRP-8803 in obese participants.,Study Goals:,Aims to assess pharmacok...

Alcidion Secures Major Deal with Peninsula Health for Miya Precision...

Highlights,Alcidion,signs a five-year contract with Peninsula Health.,Miya Precision platform to enhance patient data management and hospital operatio...

Healthscope Cancels Bupa Deal, Increasing Costs for Millions

Highlights:,Termination of Healthscope-Bupa Agreement:,Healthscope (,ASX:HSO,) has,terminated,its agreement with Bupa and other not-for-profit insurer...

Millions of Australians Face Loss of Coverage at 38 Private Hospital...

Highlights:,Coverage Termination,:,Over 6 million Australians are set to lose coverage at 38 private hospitals due to Healthscope's withdrawal from ag...

Tryptamine Therapeutics (ASX:TYP) Advances Obesity-Focused Psilocin...

Highlights,Tryptamine Therapeutics administers TRP-8803 to the first obese participant in a Phase 1b study.,Study explores pharmacokinetics difference...

Race Oncology (ASX:RAC) Advances FTO Drug Discovery

Highlights,Discovery of 39 molecular candidates targeting the m6A RNA demethylase protein.,Findings,validated,using advanced NMR spectroscopy and reso...

Algorae Pharma Advances Drug Development with AlgoraeOS

Highlights,Algorae,Pharmaceuticals,identifies,24 new drug targets using AI,.,Preclinical studies to assess targets for oncology treatments,.,Expansion...

Knosys Secures Two-Year Contract Extension with Healthdirect

Highlights,Knosys extends SaaS contract with,Healthdirect,until 2027,.,KnowledgeIQ,continues as a core tool in healthcare and beyond,.,Shares of Knosy...

Race Oncology Identifies 39 FTO Inhibitors for Cancer Therapy

Highlights,Race Oncology discovers 39 molecules targeting cancer-linked proteins,.,Focus on FTO inhibition, key in cancer RNA regulation,.,Collaborati...

Race Oncology’s FTO Breakthrough: Pioneering RNA Epigenetics for New...

Highlights,Race Oncology discovers unique FTO inhibitors in RNA epigenetics research,.,Program,identifies,39 molecular candidates with potential for p...

PainChek Targets FDA Approval for Its Adult App Expansion

Highlights,PainChek,has applied for FDA De Novo approval for its Adult App.,US-based validation study completion supports the application.,Partnership...

Singular Health Partners with Miami Clinic for 3D Imaging Breakthrou...

Highlights,Singular Health announces partnership with Miami-based health clinic,.,Focus on advancing its 3Dicom technology through a commercial pilot,...

Biotron Limited Rolls Out New Shares on ASX

Highlights:,Biotron Limited issued 20,751 fully paid ordinary shares on the ASX.,The share issuance results from the exercise of options and conversio...

Sonic Healthcare Ltd (ASX: SHL) Up 4% After AGM Update

Highlights:,Sonic Healthcare (ASX: SHL) shares rise 4% to $27.30 after providing key updates during its AGM.,The company reported $9 billion in FY24 r...